PE-induced apoptosis in SMMC-7721 cells: Involvement of Erk and Stat signalling pathways

International Journal of Molecular Medicine

Volumn 34, Issue 1, 2014, Pages 119-129

  Xue, Li ^a,b   Li, Ming ^b   Chen, Teng ^a   Sun, Haifeng ^c   Zhu, Jie ^a   Li, Xia ^d   Wu, Feng ^b   Wang, Biao ^b   Li, Juping ^e   Chen, Yanjiong ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^c Hospital of Shaanxi Province   (China)

^d LANZHOU UNIVERSITY   (China)

^e NORTHWEST UNIVERSITY OF POLITICAL SCIENCE AND LAW   (China)

Author keywords

Apoptosis; Erk; Phosphatidylethanolamine; SMMC 7721 cells; Stat

Indexed keywords

CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE 6; PHOSPHATIDYLETHANOLAMINE; PROTEIN BAX; PROTEIN BCL 2; STAT PROTEIN; STAT1 PROTEIN; ANTINEOPLASTIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE; STAT1 PROTEIN, HUMAN; STAT2 PROTEIN; STAT2 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; CELL CYCLE; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; LIVER CELL; METABOLISM; MITOCHONDRION; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTES; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; PHOSPHATIDYLETHANOLAMINES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR;

EID: 84902688399     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1777     Document Type: Article

References (54)

1. Zhao M: Lantibiotics as probes for phosphatidylethanolamine. Amino Acids 41: 1071-1079, 2011.
2. Post JA, Bijvelt JJ and Verkleij AJ: Phosphatidylethanolamine and sarcolemmal damage during ischemia or metabolic inhibition of heart myocytes. Am J Physiol 268: H773-H780, 1995.
3. Zhao M, Li Z and Bugenhagen S: 99mTc-labeled duramycin as a novel phosphatidylethanolamine-binding molecular probe. J Nucl Med 49: 1345-1352, 2008.
4. Yao Y, Huang C, Li ZF, et al: Exogenous phosphatidylethanolamine induces apoptosis of human hepatoma HepG2 cells via the bcl-2/Bax pathway. World J Gastroenterol 15: 1751-1758, 2009.
5. Keeble JA and Gilmore AP: Apoptosis commitment-translating survival signals into decisions on mitochondria. Cell Res 17: 976-984, 2007. (Pubitemid 350261795)
6. Itoh K, Hase H, Kojima H, Saotome K, Nishioka K and Kobata T: Central role of mitochondria and p53 in Fas-mediated apoptosis of rheumatoid synovial fibroblasts. Rheumatology (Oxford) 43: 277-285, 2004. (Pubitemid 38313174)
7. Suen DF, Norris KL and Youle RJ: Mitochondrial dynamics and apoptosis. Genes Dev 22: 1577-1590, 2008. (Pubitemid 351846838)
8. Adams JM and Cory S: The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26: 1324-1337, 2007. (Pubitemid 46328466)
9. Chipuk JE and Green DR: How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 18: 157-164, 2008.
10. Jiang L, Liu Y, Ma MM, Tang YB, Zhou JG and Guan YY: Mitochondria dependent pathway is involved in the protective effect of bestrophin-3 on hydrogen peroxide-induced apoptosis in basilar artery smooth muscle cells. Apoptosis 18: 556-565, 2013.
11. Brunelle JK and Letai A: Control of mitochondrial apoptosis by the Bcl-2 family. J Cell Sci 122: 437-441, 2009.
12. Fan Y, Chen H, Qiao B, et al: Opposing effects of ERK and p38 MAP kinases on HeLa cell apoptosis induced by dipyrithione. Mol Cells 23: 30-38, 2007. (Pubitemid 46443895)
13. Hetman M, Kanning K, Cavanaugh JE and Xia Z: Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J Biol Chem 274: 22569-22580, 1999.
14. Tran SE, Holmstrom TH, Ahonen M, Kahari VM and Eriksson JE: MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J Biol Chem 276: 16484-16490, 2001.
15. Boucher MJ, Morisset J, Vachon PH, Reed JC, Lainé J and Rivard N: MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. J Cell Biochem 79: 355-369, 2000.
16. Kovarik P, Mangold M, Ramsauer K, et al: Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression. EMBO J 20: 91-100, 2001. (Pubitemid 32099105)
17. Battle TE and Frank DA: The role of STATs in apoptosis. Curr Mol Med 2: 381-392, 2002. (Pubitemid 35452886)
18. Wen Z, Zhong Z and Darnell JE Jr: Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241-250, 1995.
19. Levy DE and Darnell JE Jr: Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3: 651-662, 2002. (Pubitemid 34987786)
20. Schindler C, Shuai K, Prezioso VR and Darnell JE Jr: Pillars article: interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257: 809-813, 1992.
21. Townsend PA, Scarabelli TM, Davidson SM, Knight RA, Latchman DS and Stephanou A: STAT-1 interacts with p53 to enhance DNA damage-induced apoptosis. J Biol Chem 279: 5811-5820, 2004. (Pubitemid 38220612)
22. Townsend PA, Cragg MS, Davidson SM, et al: STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage. J Cell Sci 118: 1629-1639, 2005. (Pubitemid 40691891)
23. Stephanou A, Brar BK, Knight RA and Latchman DS: Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death Differ 7: 329-330, 2000. (Pubitemid 30192982)
24. Pérez MJ and Cederbaum AI: Antioxidant and pro-oxidant effects of a manganese porphyrin complex against CYP2E1-dependent toxicity. Free Radic Biol Med 33: 111-127, 2002. (Pubitemid 34681013)
25. Baracca A, Sgarbi G, Solaini G and Lenaz G: Rhodamine 123 as a probe of mitochondrial membrane potential: evaluation of proton flux through F(0) during ATP synthesis. Biochim Biophys Acta 1606: 137-146, 2003. (Pubitemid 37267877)
26. Nera MS, Vanderbeek G, Johnson RO, Ruben LN and Clothier RH: Phosphatidylserine expression on apoptotic lymphocytes of Xenopus laevis, the South African clawed toad, as a signal for macrophage recognition. Dev Comp Immunol 24: 641-652, 2000. (Pubitemid 30261488)
27. Murphy KM, Ranganathan V, Farnsworth ML, Kavallaris M and Lock RB: Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death Differ 7: 102-111, 2000. (Pubitemid 30153768)
28. Johnson TL, Lai MB, Lai JC and Bhushan A: Inhibition of cell proliferation and MAP kinase and akt pathways in oral squamous cell carcinoma by genistein and biochanin A. Evid Based Complement Alternat Med 7: 351-358, 2010.
29. Hellebrand EE and Varbiro G: Development of mitochondrial permeability transition inhibitory agents: a novel drug target. Drug Discov Ther 4: 54-61, 2010.
30. Tomasello F, Messina A, Lartigue L, et al: Outer membrane VDAC1 controls permeability transition of the inner mitochondrial membrane in cellulo during stress-induced apoptosis. Cell Res 19: 1363-1376, 2009.
31. Orrenius S: Mitochondrial regulation of apoptotic cell death. Toxicol Lett 149: 19-23, 2004.
32. Ling YH, Lin R and Perez-Soler R: Erlotinib induces mitochondrial- mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK. Mol Pharmacol 74: 793-806, 2008.
33. Kirkin V, Joos S and Zörnig M: The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta 1644: 229-249, 2004. (Pubitemid 38281277)
34. Adams JM and Cory S: Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 26: 61-66, 2001. (Pubitemid 32124712)
35. Newmeyer DD and Ferguson-Miller S: Mitochondria: releasing power for life and unleashing the machineries of death. Cell 112: 481-490, 2003. (Pubitemid 36263081)
36. Tsujimoto Y: Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 195: 158-167, 2003.
37. Baek D, Nam J, Koo YD, et al: Bax-induced cell death of Arabidopsis is meditated through reactive oxygen-dependent and -independent processes. Plant Mol Biol 56: 15-27, 2004. (Pubitemid 40134259)
38. Kondo K, Obitsu S, Ohta S, Matsunami K, Otsuka H and Teshima R: Poly(ADP-ribose) polymerase (PARP)-1-independent apoptosis-inducing factor (AIF) release and cell death are induced by eleostearic acid and blocked by alpha-tocopherol and MEK inhibition. J Biol Chem 285: 13079-13091, 2010.
39. 2+ and ROS in alpha-tocopheryl succinate-induced mitochondrial permeabilization. Int J Cancer 127: 1823-1832, 2010.
40. Yip KW and Reed JC: Bcl-2 family proteins and cancer. Oncogene 27: 6398-6406, 2008.
41. Kroemer G and Reed JC: Mitochondrial control of cell death. Nat Med 6: 513-519, 2000. (Pubitemid 30305900)
42. Hengartner MO: The biochemistry of apoptosis. Nature 407: 770-776, 2000.
43. Paris C, Bertoglio J and Bréard J: Lysosomal and mitochondrial pathways in miltefosine-induced apoptosis in U937 cells. Apoptosis 12: 1257-1267, 2007. (Pubitemid 46890382)
44. Johnson GL and Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298: 1911-1912, 2002. (Pubitemid 35425238)
45. Wang X, Martindale JL and Holbrook NJ: Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 275: 39435-39443, 2000. (Pubitemid 32058968)
46. Bacus SS, Gudkov AV, Lowe M, et al: Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene 20: 147-155, 2001. (Pubitemid 32150260)
47. Chang L and Karin M: Mammalian MAP kinase signalling cascades. Nature 410: 37-40, 2001. (Pubitemid 32225829)
48. Tamura Y, Simizu S and Osada H: The phosphorylation status and anti-apoptotic activity of Bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondria. FEBS Lett 569: 249-255, 2004. (Pubitemid 38844627)
49. Olson JM and Hallahan AR: p38 MAP kinase: a convergence point in cancer therapy. Trends Mol Med 10: 125-129, 2004. (Pubitemid 38293348)
50. Dhanasekaran DN and Reddy EP: JNK signaling in apoptosis. Oncogene 27: 6245-6251, 2008.
51. Yang J and Stark GR: Roles of unphosphorylated STATs in signaling. Cell Res 18: 443-451, 2008. (Pubitemid 351498851)
52. Lee HJ, Oh YK, Rhee M, et al: The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN. J Mol Biol 369: 967-984, 2007. (Pubitemid 46754063)
53. Krasilnikov M, Ivanov VN, Dong J and Ronai Z: ERK and PI3K negatively regulate STAT-transcriptional activities in human melanoma cells: implications towards sensitization to apoptosis. Oncogene 22: 4092-4101, 2003. (Pubitemid 36819649)
54. Xu B, Abdel-Fattah R, Yang L, Crenshaw SA, Black MB and Hinton BT: Testicular lumicrine factors regulate ERK, STAT, and NFKB pathways in the initial segment of the rat epididymis to prevent apoptosis. Biol Reprod 84: 1282-1291, 2011.